Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07565974 · ClinicalTrials.gov registry record · Phase 2
THC Versus THC/CBD Versus Placebo to Improve Sleep Quality for Patients With Solid Organ Cancer and Insomnia
A Phase 2 study, sponsored by Mayo Clinic.
- Not yet
- Registry status
- Phase 2
- Development phase
- 69
- Enrollment target
NCT07565974: Clinical Trial Phase 2 study, sponsored by Mayo Clinic.
NCT07565974 is a Phase 2 study that has not yet begun recruiting, run by Mayo Clinic. The registered enrollment target is 69 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07565974, a Phase 2 study, has not yet begun recruiting, sponsored by Mayo Clinic.
- NOT YET RECRUITING
- Registry status
- Phase 2
- Development phase
- 69 participants
- Enrollment target
Study Summary
This phase II trial compares THC versus (vs.) THC with CBD vs. placebo to improve sleep quality for patients with solid organ cancer and insomnia. Many patients who are diagnosed with cancer struggle with sleep disorders after receiving a diagnosis. Insomnia is the most reported sleep disturbance amongst cancer patients, often stemming from physical changes from tumor growth and surgery, side effects from supportive care and chemotherapy, and stress associated with the diagnosis. THC with or without CBD may improve insomnia symptoms and sleep quality.
Interventions
- PROCEDURE Biospecimen Collection
- DRUG Placebo Administration
- DRUG Single Agent Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 69 participants |
| Start Date | 2026-06-01 |
| Est. Completion | 2027-09-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07565974
The ClinicalTrials.gov registry entry for NCT07565974 describes a study currently listed as not yet recruiting, categorized as Phase 2. The registered enrollment target is 69 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Biospecimen Collection is the first listed.
NCT07565974 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07565974 about?
NCT07565974 is a clinical study titled "THC Versus THC/CBD Versus Placebo to Improve Sleep Quality for Patients With Solid Organ Cancer and Insomnia". This phase II trial compares THC versus (vs.) THC with CBD vs. placebo to improve sleep quality for patients with solid organ cancer and insomnia. Many patients who are diagnosed with cancer struggle with sleep disorders after receiving a diagnosis. Insomnia is the most reported sleep disturbance am...
What is the current status of trial NCT07565974?
This trial is currently not yet recruiting. It is a Phase 2 study. The enrollment target is 69 participants. The study started on 2026-06-01. Estimated completion is 2027-09-01.
What interventions are being tested in trial NCT07565974?
The interventions under investigation include: Biospecimen Collection (PROCEDURE), Placebo Administration (DRUG), Single Agent Therapy (DRUG).
Who is sponsoring clinical trial NCT07565974?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.